{"id":"https://openalex.org/W1963776310","doi":"https://doi.org/10.1089/cap.2013.0077","title":"Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder","display_name":"Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder","publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W1963776310","doi":"https://doi.org/10.1089/cap.2013.0077","mag":"1963776310","pmid":"https://pubmed.ncbi.nlm.nih.gov/24815910","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4026374"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2013.0077","doi":"https://doi.org/10.1089/cap.2013.0077","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0077","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4026374","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024208230","display_name":"Ann Catherine Childress","orcid":"https://orcid.org/0000-0001-5782-7891","observed_orcids":["https://orcid.org/0000-0001-5782-7891"]},"institutions":[{"id":"https://openalex.org/I4210146954","display_name":"Center for Psychiatry and Behavioral Medicine","ror":"https://ror.org/04tf0ye64","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146954"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ann C. Childress","raw_affiliation_strings":["Center for Psychiatry and Behavioral Medicine Inc, Las Vegas, Nevada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Psychiatry and Behavioral Medicine Inc, Las Vegas, Nevada","institution_ids":["https://openalex.org/I4210146954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102774504","display_name":"Andrew J. Cutler","orcid":"https://orcid.org/0000-0001-5800-0378","observed_orcids":["https://orcid.org/0000-0001-5800-0378"]},"institutions":[{"id":"https://openalex.org/I4210143592","display_name":"Meridien Research","ror":"https://ror.org/042bavh06","country_code":"US","type":"other","lineage":["https://openalex.org/I4210143592"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Cutler","raw_affiliation_strings":["Florida Clinical Research Center, LLC, Bradenton, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Florida Clinical Research Center, LLC, Bradenton, Florida","institution_ids":["https://openalex.org/I4210143592"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082771218","display_name":"Keith E. Saylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith Saylor","raw_affiliation_strings":["NeuroScience, Inc, Herndon, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeuroScience, Inc, Herndon, Virginia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003133423","display_name":"Maria Gasior","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Gasior","raw_affiliation_strings":["Clinical Medicine, Shire Development LLC, Wayne, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Medicine, Shire Development LLC, Wayne, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mohamed Hamdani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed Hamdani","raw_affiliation_strings":["Biostats, Shire Development LLC, Wayne, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostats, Shire Development LLC, Wayne, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038305189","display_name":"M. Celeste Ferreira\u2010Cornwell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Celeste Ferreira-Cornwell","raw_affiliation_strings":["Clinical Medicine, Shire Development LLC, Wayne, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Medicine, Shire Development LLC, Wayne, Pennsylvania","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042787535","display_name":"Robert L. Findling","orcid":"https://orcid.org/0000-0002-7654-5782","observed_orcids":["https://orcid.org/0000-0002-7654-5782"]},"institutions":[{"id":"https://openalex.org/I1298154867","display_name":"Kennedy Krieger Institute","ror":"https://ror.org/05q6tgt32","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298154867"]},{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert L. Findling","raw_affiliation_strings":["Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University and the Kennedy Krieger Institute, Baltimore, Maryland","institution_ids":["https://openalex.org/I1298154867","https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5024208230"],"corresponding_institution_ids":["https://openalex.org/I4210146954"],"apc_list":null,"apc_paid":null,"fwci":0.2147,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.56227323,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"24","issue":"4","first_page":"210","last_page":"217"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisdexamfetamine-dimesylate","display_name":"lisdexamfetamine dimesylate","score":0.9959999918937683},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9940000176429749},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.9819999933242798},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9589999914169312},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.6869999766349792},{"id":"https://openalex.org/keywords/adhd-symptom-improvement","display_name":"ADHD symptom improvement","score":0.597000002861023},{"id":"https://openalex.org/keywords/study-completion","display_name":"study completion","score":0.6330000162124634},{"id":"https://openalex.org/keywords/baseline-quality-of-life","display_name":"baseline quality of life","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.6735321283340454},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6201348900794983},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.6016584634780884},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5533351302146912},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5314093232154846},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.46188610792160034},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.43615150451660156},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4305700659751892},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3857341408729553},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3739463984966278},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3082388639450073},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3061785101890564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17094168066978455},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.13764604926109314},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069478","descriptor_name":"Lisdexamfetamine Dimesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/cap.2013.0077","doi":"https://doi.org/10.1089/cap.2013.0077","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2013.0077","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4026374","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4026374","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Child Adolesc Psychopharmacol","raw_type":"Text"},{"id":"pmid:24815910","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24815910","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Comparative Study"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4026374","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4026374","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Child Adolesc Psychopharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W76668800","https://openalex.org/W1533661357","https://openalex.org/W1853960255","https://openalex.org/W1964396391","https://openalex.org/W1966782848","https://openalex.org/W1971185325","https://openalex.org/W1977733462","https://openalex.org/W1985935801","https://openalex.org/W1992861435","https://openalex.org/W2000421003","https://openalex.org/W2008237562","https://openalex.org/W2018083579","https://openalex.org/W2018548383","https://openalex.org/W2034939353","https://openalex.org/W2043954566","https://openalex.org/W2048937574","https://openalex.org/W2063445955","https://openalex.org/W2091621243","https://openalex.org/W2096544279","https://openalex.org/W2098399548","https://openalex.org/W2107845557","https://openalex.org/W2109605723","https://openalex.org/W2114290463","https://openalex.org/W2128463513","https://openalex.org/W2131679908","https://openalex.org/W2138818661","https://openalex.org/W2153037725","https://openalex.org/W2417517396","https://openalex.org/W2584452351"],"related_works":["https://openalex.org/W2090246833","https://openalex.org/W2014952679","https://openalex.org/W2131679908","https://openalex.org/W7097991620","https://openalex.org/W2041139943","https://openalex.org/W1985935801","https://openalex.org/W2109605723","https://openalex.org/W76668800","https://openalex.org/W2996557655","https://openalex.org/W2045793565"],"abstract_inverted_index":{"OBJECTIVES:":[0],"The":[1],"purpose":[2],"of":[3,13,197],"this":[4],"study":[5,40,122,125,205],"was":[6,61],"to":[7,73,160,171,182],"assess":[8],"long-term":[9],"improvement":[10],"in":[11,16,35,81,190,241],"quality":[12],"life":[14],"(QOL)":[15],"adolescents":[17,242],"with":[18,23,29,106,135,152,175,239,243,250],"attention-deficit/hyperactivity":[19],"disorder":[20],"(ADHD)":[21],"treated":[22,31],"lisdexamfetamine":[24],"dimesylate":[25],"(LDX).":[26],"METHODS:":[27],"Adolescents":[28],"ADHD":[30,82,234],"for":[32,63,104,121,173,184,225,228],"\u22653":[33],"weeks":[34],"a":[36,42],"4":[37,49],"week,":[38],"placebo-controlled":[39],"entered":[41],"1":[43],"year,":[44],"open-label":[45,79],"study.":[46],"After":[47],"the":[48,90,115],"week":[50,74,156,161,187,203,223],"dose":[51],"optimization":[52],"(30,":[53],"50,":[54],"and":[55,89,102,120,158,180,233],"70":[56],"mg/day":[57],"LDX)":[58],"period,":[59],"treatment":[60],"maintained":[62,159],"48":[64],"additional":[65],"weeks.":[66],"Change":[67],"from":[68,169,237],"baseline":[69,111,136,176,198,238,251],"(of":[70,78],"prior":[71],"study)":[72,80],"52/early":[75],"termination":[76],"(ET)":[77],"Rating":[83],"Scale":[84],"IV":[85],"(ADHD-RS-IV)":[86],"assessed":[87,95],"effectiveness,":[88],"Youth":[91],"QOL-Research":[92],"Version":[93],"(YQOL-R)":[94],"participant-perceived":[96],"QOL.":[97,254],"Post-hoc":[98],"analyses":[99,130],"described":[100],"effectiveness":[101],"QOL":[103,109,139,179,232],"participants":[105,174,249],"self-perceived":[107,137,177,252],"poor":[108,138,178,253],"at":[110,222],"(\u22651":[112],"SD":[113],"below":[114],"mean)":[116],"versus":[117,124,141],"all":[118,142,185],"others,":[119],"completers":[123,206,226],"noncompleters.":[126,229],"RESULTS:":[127],"These":[128],"post-hoc":[129],"included":[131],"265":[132],"participants.":[133],"Participants":[134],"(n=32)":[140],"others":[143],"(n=232)":[144],"exhibited":[145],"robust":[146],"YQOL-R":[147,199,209],"perceptual":[148],"score":[149,167,216],"changes":[150,217],"(improvement)":[151],"LDX,":[153],"emerging":[154],"by":[155],"28":[157],"52/ET.":[162],"Week":[163],"52/ET":[164,188,224],"mean":[165],"change":[166],"ranged":[168],"+9.8":[170],"+17.6":[172],"+0.4":[181],"+5.1":[183],"others;":[186],"improvements":[189,210,246],"ADHD-RS-IV":[191,214],"total":[192,200,215],"scores":[193],"were":[194,218],"similar,":[195],"regardless":[196],"score.":[201],"At":[202],"52/ET,":[204],"had":[207],"greater":[208],"than":[211,227],"did":[212],"noncompleters;":[213],"also":[219],"numerically":[220],"larger":[221],"CONCLUSION:":[230],"Participant-perceived":[231],"symptoms":[235],"improved":[236],"LDX":[240],"ADHD;":[244],"greatest":[245],"occurred":[247],"among":[248]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}